One study found that this miRNA might help prevent anti-tumor immunity through the accumulation of myeloid-derived cells in the microenvironment, promoting tumor growth [186], while another study showed that miR-494 suppresses the progression of breast cancer, through downregulation of CXCR4-mediated oncogenic communication [188]. The gene discussed is CXCR4; the disease is neoplasm.